National Cancer Institute; Notice of Closed Meetings, 46307-46308 [E8-18278]
Download as PDF
Federal Register / Vol. 73, No. 154 / Friday, August 8, 2008 / Notices
reached. Requests for an opportunity to
make a presentation from individuals or
organizations that did not make such a
request in advance may be granted if
time permits.
Persons who submit a notice of
participation in advance of the hearing
should check in at the on-site
registration desk between 8 a.m. and 9
a.m. Persons who wish to submit a
notice of participation on-site on the
day of the hearing may do so at the
registration desk between 8 a.m. and 9
a.m. We encourage all participants to
attend the entire hearing. Because the
hearing will be held in a Federal
building, hearing participants must
present photo identification and plan
adequate time to pass through the
security system.
We may post all submissions and
received comments without change to
https://www.regulations.gov, including
any personal information provided.
pwalker on PROD1PC71 with NOTICES
VI. Request for Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments for consideration at or after
the hearing in addition to, or in place of,
a request for an opportunity to make an
oral presentation (see section V of this
document). Submit a single copy of
electronic comments or two paper
copies of any mailed comments, except
that individuals may submit one paper
copy. Comments are to be identified
with the docket number found in
brackets in the heading of this
document. Received comments may be
seen in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.
Please note that on January 15, 2008,
the FDA Division of Dockets
Management Web site transitioned to
the Federal Dockets Management
System (FDMS). FDMS is a
Government-wide, electronic docket
management system. Electronic
comments or submissions will be
accepted by FDA only through FDMS at
https://www.regulations.gov.
VII. Transcripts
Please be advised that as soon as a
transcript is available, it will be
accessible at https://www.fda.gov/ohrms/
dockets/ac/acmenu.htm. It may be
viewed at the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. A transcript
will also be available in either hardcopy
or on CD-ROM after submission of a
Freedom of Information request. Written
requests are to be sent to Division of
Freedom of Information (HFI–35), Office
VerDate Aug<31>2005
17:25 Aug 07, 2008
Jkt 214001
of Management Programs, Food and
Drug Administration, 5600 Fishers
Lane, rm. 6–30, Rockville, MD 20857.
VIII. References
We have placed the following
references on display in the Division of
Dockets Management (see ADDRESSES)
and interested parties may see them
between 9 a.m. and 4 p.m., Monday
through Friday. (FDA has verified the
Web site addresses, but FDA is not
responsible for any subsequent changes
to the Web site after this document
publishes in the Federal Register.)
1. Center for Food Safety and Applied
Nutrition, U.S. Food and Drug
Administration, ‘‘Notice to Manufacturers,
Label Declaration of Allergenic Substances in
Foods,’’ June 10, 1996.
2. Food and Drug Administration, 2001,
‘‘Statement of Policy for Labeling and
Preventing Cross-contact of Common Food
Allergens; Compliance Policy Guide’’
accessible at https://www.fda.gov/ora/
compliance_ref/cpg/cpgfod/cpg555–250.htm
3. Center for Food Safety and Applied
Nutrition, U.S. Food and Drug
Administration, ‘‘Report to the Committee on
Health, Education, Labor, and Pensions,
United States Senate and the Committee on
Energy and Commerce, United States House
of Representatives,’’ July 2006, accessible at
https://www.cfsan.fda.gov/~acrobat/
alrgrep.pdf
`
4. Verrill, Linda and Conrad J. Choiniere.
(2009). ‘‘Are Food Allergen Advisory
Statements Really Warnings?: Variation in
Consumer Preferences and Consumption
Decisions,’’ Journal of Food Products
Marketing. 15(2) (accepted for publication).
5. Wogalter, M.S., M.J. Kalsher, R. Rashid,
(1999), ‘‘Effect of Signal Word and Source
Attribution on Judgments of Warning
Credibility and Compliance Likelihood,’’
International Journal of Industrial
Ergonomics. 1999 24:185–192.
6. Hefle, S.L., T.J. Furlong, L. Niemann, H.
Lemon-Mule, S. Sicherer, S.L. Taylor, (2007),
‘‘Consumer Attitudes and Risks Associated
With Packaged Foods Having Advisory
Labeling Regarding the Presence of Peanuts,’’
Journal of Allergy and Clinical Immunology,
120(1):171–176.
7. Food Allergy Issues Alliance, ‘‘Food
Allergen Labeling Guidelines,’’ May 2001.
8. Canadian Food Inspection Agency,
‘‘Precautionary Labelling Regarding Food
Allergens in Pre-packaged Foods’’ September
25, 2007, accessible at https://
www.inspection.gc.ca/english/fssa/invenq/
inform/20070925e.shtml on March 26, 2008.
9. Australian Food and Grocery Council
Allergen Forum, ‘‘Food Industry Guide to
Allergen Management and Labelling,’’ 2007
revised edition, accessible at https://
www.allergenbureau.net/downloads/allergenguide/Allergen_Guide_2007.pdf on March 26,
2008.
10. Levy, A.S., ‘‘Review of Research
Communicating Warning Information,’’
Consumer Studies Branch, Office of
Scientific Analysis and Support, Center for
Food Safety and Applied Nutrition, Food and
Drug Administration, June 1997.
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
46307
Dated: July 30, 2008.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E8–18280 Filed 8–7–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Initial Review Group,
Subcommittee I—Career Development.
Date: September 30–October 1, 2008.
Time: 8 a.m. to 5 a.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza National Airport,
1480 Crystal Drive, Arlington, VA
22202.
Contact Person: Sonya Roberson, PhD,
Scientific Review Officer, Resources
And Training Review Branch, Division
of Extramural Activities, National
Cancer Institute, 6116 Executive Blvd.,
Room 8109, Bethesda, MD 20892, 301–
594–1182, robersos@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group,
Subcommittee H—Clinical Groups.
Date: October 13–14, 2008.
Time: 8 a.m. to 9 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks
Hill Road, Bethesda, MD 20814.
Contact Person: Timothy C. Meeker,
MD, PhD, Scientific Review Officer,
Resources and Training Review Branch,
Division of Extramural Activities,
National Cancer Institute, 6116
Executive Boulevard, Room 8103,
Bethesda, MD 20892, (301) 594–1279,
meekert@mail.nih.gov.
E:\FR\FM\08AUN1.SGM
08AUN1
46308
Federal Register / Vol. 73, No. 154 / Friday, August 8, 2008 / Notices
Name of Committee: National Cancer
Institute Initial Review Group,
Subcommittee G—Education.
Date: October 23–24, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Sand Key Resort,
1160 Gulf Blvd., Clearwater, FL 33767.
Contact Person: Jeannette F Korczak,
PhD, Scientific Review Officer, Review
Training Resources Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Blvd.,
Room 8115, Bethesda, MD 20892, 301–
496–9767, korczakj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: July 31, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–18278 Filed 8–7–08; 8:45 am]
National Institute of Mental Health;
Notice of Closed Meeting
pwalker on PROD1PC71 with NOTICES
Dated: August 1, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–18248 Filed 8–7–08; 8:45 am]
Dated: August 1, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–18243 Filed 8–7–08; 8:45 am]
BILLING CODE 4140–01–P
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National
Institute of Mental Health Special
Emphasis Panel: SBIR Phase II—Topics
44, 53 and 55B.
Date: August 21, 2008.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate
contract proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Jkt 214001
(Catalogue of Federal Domestic Assistance
Program Nos. 93.242, Mental Health Research
Grants; 93.281, Scientist Development
Award, Scientist Development Award for
Clinicians, and Research Scientist Award;
93.282, Mental Health National Research
Service Awards for Research Training,
National Institutes of Health, HHS)
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
17:25 Aug 07, 2008
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
VerDate Aug<31>2005
Boulevard, Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Aileen Schulte, PhD,
Scientific Review Administrator,
Division of Extramural Activities,
National Institute of Mental Health,
NIH, Neuroscience Center, 6001
Executive Blvd, Room 6140, MSC 9608,
Bethesda, MD 20892–9608, 301–443–
1225, aschulte@mail.nih.gov.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Newborn Screening
Network Coordinating Center.
Date: August 27, 2008.
Time: 2:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852, (Telephone Conference Call).
Contact Person: Samiyyah Manning,
Extramural Support Assistant, Division of
Scientific Review, National Institute of Child
Health, and Human Development, NIH, 6100
Executive Boulevard, Room 5B01, Bethesda,
MD 20892–7510, (301) 435–6899,
mannings@mail.nih.gov.
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Deafness and Other
Communication Disorders Advisory
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Deafness and
Other Communication Disorders Advisory
Council.
Date: September 12, 2008.
Closed: 8:30 a.m. to 10:50 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Bethesda, MD
20892.
Open: 10:50 a.m. to 2:30 p.m.
Agenda: Staff reports on divisional,
programmatic, and special activities.
E:\FR\FM\08AUN1.SGM
08AUN1
Agencies
[Federal Register Volume 73, Number 154 (Friday, August 8, 2008)]
[Notices]
[Pages 46307-46308]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-18278]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Initial Review Group,
Subcommittee I--Career Development.
Date: September 30-October 1, 2008.
Time: 8 a.m. to 5 a.m.
Agenda: To review and evaluate grant applications.
Place: Crowne Plaza National Airport, 1480 Crystal Drive,
Arlington, VA 22202.
Contact Person: Sonya Roberson, PhD, Scientific Review Officer,
Resources And Training Review Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Blvd., Room 8109,
Bethesda, MD 20892, 301-594-1182, robersos@mail.nih.gov.
Name of Committee: National Cancer Institute Initial Review Group,
Subcommittee H--Clinical Groups.
Date: October 13-14, 2008.
Time: 8 a.m. to 9 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.
Contact Person: Timothy C. Meeker, MD, PhD, Scientific Review
Officer, Resources and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Boulevard, Room
8103, Bethesda, MD 20892, (301) 594-1279, meekert@mail.nih.gov.
[[Page 46308]]
Name of Committee: National Cancer Institute Initial Review Group,
Subcommittee G--Education.
Date: October 23-24, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Sand Key Resort, 1160 Gulf Blvd., Clearwater, FL
33767.
Contact Person: Jeannette F Korczak, PhD, Scientific Review
Officer, Review Training Resources Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room
8115, Bethesda, MD 20892, 301-496-9767, korczakj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: July 31, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-18278 Filed 8-7-08; 8:45 am]
BILLING CODE 4140-01-P